Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to anoikis through inhibition of bim

Medicine and Dentistry

• Breast Cancer 100%
• Cancer Cell 100%
• CD147 Antigen 100%
• Anoikis 100%
• Cancer Therapy 8%
• Metastatic Carcinoma 8%
• Extracellular Matrix 8%
• Cell Viability 8%
• Immunoglobulin 8%
• Small Interfering RNA 8%
• Tumor Cell 8%
• MEK Inhibitor 8%
• Carcinoma Cell 8%
• Programmed Cell Death 8%
• Fibronectin 8%
• Cell Signaling Pathway 8%
• Antiinfective Agent 8%
• Anchorage 8%
• Breast Carcinoma 8%
• Short Hairpin RNA 8%
• DNA Fragmentation 8%
• Proteasome Inhibitor 8%
• U0126 8%
• Glycoprotein 8%
• Mitogen-Activated Protein Kinase 8%
• Caspase 3 8%
• RNAI 8%
• Attachment 8%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Anoikis 100%
• Basigin 100%
• Small Interfering RNA 16%
• Proteasome Inhibitor 8%
• Cell Viability 8%
• Glycoprotein 8%
• Surface Area 8%
• DNA Fragmentation 8%
• U0126 8%
• Mitogen-Activated Protein Kinase 8%
• MEK Inhibitor 8%
• Small Hairpin RNA 8%
• Intravenous Immunoglobulin 8%
• Caspase 3 8%
• RNAI 8%
• Fibronectin 8%
• Programmed Cell Death 8%
• Deficiency 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• CD147 Antigen 100%
• Malignant Neoplasm 33%
• Mitogen Activated Protein Kinase 8%
• 1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene 8%
• Antiinfective Agent 8%
• Mitogen Activated Protein Kinase Kinase Inhibitor 8%
• Small Interfering RNA 8%
• Short Hairpin RNA 8%
• Glycoprotein 8%
• Immunoglobulin 8%
• Breast Carcinoma 8%
• Fibronectin 8%
• BH3 Protein 8%
• Neoplasm 8%
• Caspase 3 8%
• Proteasome Inhibitor 8%
• Epoxomicin 8%